This is a renewal of the ACTG unit for the Los Angeles area, coordinated at UCLA Medical Center and Children's Hospital of Los Angeles (CHLA) . The consortium of clinical centers now includes units at UCLA, CHLA, Harbor/UCLA General Hospital, Memorial Medical Center of Long Beach, Cedars-Sinai Medical Center, the network of Kaiser Hospitals, and Martin Luther King Hospital, all of which have therapeutic centers for HIV+ children and collectively take care of over 60% of the HIV+ children in LA County. NIH-supported clinical research centers are used at UCLA and Harbor/UCLA Hospitals. Additional centers joining our Consortium will be in South Central LA, and possibly Hawaii and Las Vegas. We plan to enroll 78 patients on therapeutic trials in the first year and similar numbers in subsequent years. Centers for HIV+ pregnant women are located at six of these sites. The Consortium has developed effective liaisons with an LA County surveillance study, community health centers performing screening of pregnant women, a county-wide social service network for HIV+ children, and community representatives. Special emphasis will be on developing protocols and entering patients on trials to prevent maternal-fetal transmission, to assess HIV vaccine efficacy, and to prevent or overcome antiviral drug resistance. Scientific liaisons with virology, immunology, pharmacology and neurodevelopmental function are well developed throughout the Consortium and nested protocols are included for developmental research, core pediatric virology, an immunology core support program component, and a pharmacology core support research component. Developmental research components for immunology, virology and neurodevelopmental function are included. Overall this effort will include 32 clinicians and basic scientists as well as administrative personnel involved in data management and statistics. The overall goal is to shorten the time between basic scientific advances and clinical applicability.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01AI027550-08
Application #
2063905
Study Section
Special Emphasis Panel (SRC (51))
Project Start
1988-09-30
Project End
1997-08-31
Budget Start
1995-09-01
Budget End
1996-08-31
Support Year
8
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Pediatrics
Type
Schools of Medicine
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Sha, Beverly E; Tierney, Camlin; Cohn, Susan E et al. (2011) Postpartum viral load rebound in HIV-1-infected women treated with highly active antiretroviral therapy: AIDS Clinical Trials Group Protocol A5150. HIV Clin Trials 12:9-23
Veloso, Valdiléa G; Bastos, Francisco I; Portela, Margareth Crisóstomo et al. (2010) HIV rapid testing as a key strategy for prevention of mother-to-child transmission in Brazil. Rev Saude Publica 44:803-11
Truong, Hong-Ha M; Sim, Myung S; Dillon, Maryanne et al. (2010) Correlation of immune activation during late pregnancy and early postpartum with increases in plasma HIV RNA, CD4/CD8 T cells, and serum activation markers. Clin Vaccine Immunol 17:2024-8
Aldrovandi, Grace M; Chu, Clara; Shearer, William T et al. (2009) Antiretroviral exposure and lymphocyte mtDNA content among uninfected infants of HIV-1-infected women. Pediatrics 124:e1189-97
Bryson, Y J; Mirochnick, M; Stek, A et al. (2008) Pharmacokinetics and safety of nelfinavir when used in combination with zidovudine and lamivudine in HIV-infected pregnant women: Pediatric AIDS Clinical Trials Group (PACTG) Protocol 353. HIV Clin Trials 9:115-25
Fletcher, Courtney V; DeVille, Jaime G; Samson, Pearl M et al. (2007) Nonlinear pharmacokinetics of high-dose recombinant fusion protein CD4-IgG2 (PRO 542) observed in HIV-1-infected children. J Allergy Clin Immunol 119:747-50
Ching, Natascha; Yang, Otto O; Deville, Jaime G et al. (2007) Pediatric HIV-1-specific cytotoxic T-lymphocyte responses suggesting ongoing viral replication despite combination antiretroviral therapy. Pediatr Res 61:692-7
Shearer, William T; DeVille, Jaime G; Samson, Pearl M et al. (2006) Susceptibility of pediatric HIV-1 isolates to recombinant CD4-IgG2 (PRO 542) and humanized mAb to the chemokine receptor CCR5 (PRO 140). J Allergy Clin Immunol 118:518-21
Lambert, John S; Moye Jr, Jack; Plaeger, Susan F et al. (2005) Association of selected phenotypic markers of lymphocyte activation and differentiation with perinatal human immunodeficiency virus transmission and infant infection. Clin Diagn Lab Immunol 12:622-31
Watts, D Heather; Lambert, John; Stiehm, E Richard et al. (2003) Progression of HIV disease among women following delivery. J Acquir Immune Defic Syndr 33:585-93

Showing the most recent 10 out of 44 publications